Haemochromatosis: an under-recognised and treatable cause of dilated cardiomyopathy

25 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Silvia Cesini

University Hospital Riuniti of Ancona, Ancona (Italy)

34 More presentations in this session

Presentation thumbnail

Acute hypertensive heart failure - when the etiology is misleading

Miss A. Burducea (Bucuresti, RO)

Presentation thumbnail

Wild type TTR amyloidosis disguised as concentric hypertensive left ventricular hypertrophy

Doctor A. Siama (Maroussi-Athens, GR)

Abstract Slides

Presentation thumbnail

"Burned-out" hypertrophic obstructive cardiomyopathy presenting as acute coronary syndrome

Doctor A. Kalogeris (Athens, GR)

Presentation thumbnail

Successful antiarrhythmic therapy with combination of quinidine and mexiletine in Purkinje-related ventricular arrhythmia, persistent atrial tachyarrhythmia and DCM associated with R814W SCN5Amutation

Doctor J. Zakrzewska-Koperska (Warsaw, PL)

Presentation thumbnail

Clinical case of effective treatment of ventricular arrhythmias with ranolazine in a 32-year-old woman with unclear aetiology cardiac inflammation

Access the full session

Session thumbnail

Poster Session 2 - Clinical Cases

The Event

Heart Failure 2019

25 May - 28 May 2019

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources